Timely Administration of IV Magnesium Sulfate in Patients With a Moderate Asthma Exacerbation
Recruiting
Early Phase 1
Interventional Study
Asthma in Children
Asthma Attack
At a Glance
- Age
- 5 – 17
- Sex
- Any
- Trial phase
- Early Phase 1
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 100 (estimated)
- Sponsor
- University of Oklahoma · Other
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Check Your Eligibility
About This Trial
This study aims to identify whether early administration of magnesium sulfate in moderate asthma exacerbations can potentially avoid admission, decrease length of stay in the emergency department (ED), decrease length of stay (LOS) in the general hospital floor vs pediatric intensive care unit (PICU), and decrease the need for respiratory support.
Trial Locations
Loading…
Loading trial locations…
Eligibility Criteria
Inclusion Criteria:
* Ages 5-17 years old
* Presents to the ED with a respiratory score in the "Moderate" range (6
* Parent(s)/Caregiver(s) speak English
Exclusion Criteria:
* Patients with chronic medical conditions including chronic pulmonary disease (other than asthma), cerebral palsy, congeni…
Contacts